Supporting companies
Menu
Search for medicines
Supporting Companies
Kusuri-no-Shiori (Japanese)
Search for medicines
海外渡航情報
Eli Lilly Japan K.K
Internal
Revised: 7/2020
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Strattera Oral Solution 0.4%
Active ingredient:
Atomoxetine hydrochloride
Dosage form:
clear and colorless solution (oral solution)
Print on wrapping:
Effects of this medicine
This medicine regulates neurotransmitters which transmit information between nerve cells in the brain, and improves symptoms such as inattention, hyperactivity or impulsiveness.
It is usually used to treat attention-deficit/hyperactivity disorder (ADHD).
Before using this medicine, be sure to tell your doctor and pharmacist
If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have: cardiovascular disease, pheochromocytoma or a history of pheochromocytoma, or angle-closure glaucoma.
If you are pregnant or breastfeeding.
If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
Your dosing schedule prescribed by your doctor is
(( to be written by a healthcare professional))
For patients younger than 18 years
: In general, this medicine should be initiated at total daily dose of 0.125 mL/kg (0.5 mg/kg of atomoxetine) and should be increased to 0.2 mL/kg (0.8 mg/kg) daily. After that, the daily dose should be increased to 0.3 mL/kg (1.2 mg/kg). The maintenance dose should range from 0.3 to 0.45 mL/kg (1.2 to 1.8 mg/kg) daily. The dose should be increased at intervals of 1 week or longer. Take this medicine in 2 divided doses daily in any case. The dose may be adjusted according to clinical requirements. However, the total daily dose should not exceed 0.45 mL/kg (1.8 mg/kg) or 30 mL (120 mg), whichever is less.
For patients aged 18 years and older
: In general, this medicine should be initiated at total daily dose of 10 mL (40 mg) and should be increased to 20 mL (80 mg) daily. The maintenance dose should range from 20 to 30 mL (80 to 120 mg) daily. The daily dose, up to 20 mL (80 mg), should be increased at intervals of 1 week or longer. After the daily dose reaches 20 mL (80 mg), the daily dose should be increased at intervals of 2 weeks or longer. Take this medicine either as a single daily dose or as 2 divided doses daily. The dose may be adjusted according to clinical requirements. However, the total daily dose should not exceed 30 mL (120 mg).
This solution contains 4 mg of atomoxetine per milliliter. Strictly follow the instructions.
Measure the dose of solution accurately by a provided pipette. Follow the instruction leaflet. Take the full-strength product, without diluting with water or mixing with beverages or food, etc.
This solution is an ocular irritant. If this solution is attached to the eye, wash the eye with water and consult with your doctor. Wash your hands or other part of your body with water, if this solution is attached to them.
If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time.
If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
Do not stop taking this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
This medicine may cause sleepiness and dizziness. Avoid driving a car or operating dangerous machinery after taking this medicine.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include nausea, loss of appetite, sleepiness, headache, abdominal pain, dry mouth, vomiting, constipation, dizziness, insomnia, weight loss and palpitation. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
general malaise, loss of appetite, yellowing of the skin or conjunctiva ocular [liver dysfunction, jaundice, liver failure]
swelling around the eyes or lips, hives, respiratory distress [anaphylaxis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
Keep out of reach of children.
Store this medicine standing its bottle straight up at room temperature (1 to 30 degrees Celsius), away from light.
Do not take after 45 days of first opening the bottle. If the additional instruction on use-by date is provided by your doctor or pharmacist, follow it. Seek advice of your doctor or pharmacist about proper disposal of unused medicines.
For healthcare professional use only :
Day
Month
Year
For further information, talk to your doctor or pharmacist.
Product name
Active Substance
Dosage form
Print on wrapping
Keywords search
All
AEGERION PHARMACEUTICALS K.K.
AMATO PHARMACEUTICAL PRODUCTS, LTD.
ASKA Pharmaceutical Co.,Ltd
AYUMI Pharmaceutical Co., Ltd.
AbbVie GK
Abbott Japan
Alfresa Pharma corporation
Amgen K. K.
Amicus Therapeutics K.K.
Asahi Kasei Pharma Corporation
Aspen Japan K.K.
Astellas Pharama Inc.
AstraZeneca K.K
BEE BRAND MEDICO DENTAL.CO.,LTD.
Baxalta, Ltd.
Bayer Yakuhin, Ltd.
Biofermin Pharmaceutical Co., Ltd.
Biogen Japan Ltd.
Biomedix Co., Ltd.
Bristol-Myers Squibb
CELLTRION HEALTHCARE Japan K.K
CHO SHINYAKU Co.,Ltd.
CSL Behring
Celgene K.K.
Ceolia Pharma Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO ESPHA CO., LTD.
DAIICHI YAKUHIN SANGYO CO., LTD.
DS Pharma Promo Co., Ltd
Daiko Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co.,Ltd.
EA Pharma Co.,Ltd.
Eisai Co., Ltd.
Eli Lilly Japan K.K
Essential Pharma Co. Ltd.
FELDSENF PHARMA Co., Ltd.
FP PHARMACEUTICAL CORPORATION
FUJI PHARMACEUTICAL CO.,LTD.
FUJI YAKUHIN CO., LTD.
FUJIFILM Toyama Chemical Co., Ltd.
FUJIMOTO PHARMACEUTICAL CORPORATION
FUSHIMI Pharmaceutical Co.,Ltd.
Ferring Pharmaceuticals Co., Ltd.
Fuji Chemical Industry Co., Ltd.
Fujinaga Pharmaceutical Co.,Ltd.
Fuso Pharmaceutical Industries, Ltd.
Gilead Sciences K. K.
GlaxoSmithKline K.K.
HIKARI PHARMACEUTICAL CO.,LTD.
HONZO Pharmaceutical Co., Ltd.
HORII PHARMACEUTICAL IND.,LTD
Hisamitsu Pharmaceutical Company
Iwakiseiyaku Co., Ltd
J-dolph pharmaceutical co., ltd.
JANSSEN PHARMACEUTICAL K.K.
JCR Pharmaceuticals Co., Ltd.
Japan Blood Products Organization
KOA BIOTECH BAY CO.,LTD.
KOA ISEI CO.,LTD.
KOBAYASHIKAKO Co.,Ltd.
KOKANDO PHARMACEUTICAL CO.,LTD.
KOTARO Pharmaceutical Co.,Ltd.
KYOSOMIRAI PHARMA CO., LTD.
KYOWA CritiCare Co.,Ltd.
KYOWA PHARMACEUTICAL INDUSTRY CO., LTD
Kaigen Pharma Co..,Ltd.
Kaken Pharmaceutical Co., Ltd.
Kenei Pharmaceutical Co,Ltd.
Kissei Pharmaceutical Co., Ltd.
Kotobuki Pharmaceutical Co., Ltd.
Kowa Co., Ltd.
Kracie Pharmaceutical.LTD.
Kyorin Pharmacetical Co.,Ltd
Kyorin Rimedio Co.,Ltd.
Kyowa Chemical Industry Co.,Ltd.
Kyowa Kirin Co.,Ltd
LTL Pharma Co., Ltd.
MIKASASEIYAKU Co.,Ltd
MIYARISAN PHARMACEUTICAL CO., LTD.
MORISHITAJINTAN CO.,LTD.
MSD K.K.
Maruho Co.,Ltd.
Maruishi Pharmaceutical. Co., Ltd.
Me Pharma Co., Ltd.
Meiji Seika Pharma Co., Ltd.
Merck Biopharma Co., Ltd
Mitsubishi Tanabe Pharma Corporation
Mochida Pharmaceutical Co., Ltd.
Mundipharma K.K.
Mylan EPD G.K.
Mylan Seiyaku Ltd.
NAKAKITA Co.,ltd
NIHON GENERIC CO.,LTD
NIHON PHARMACEUTICAL CO.,LTD.
NIHON PHARMACEUTICAL INDUSTRY CO., LTD.
NIHON SERVIER CO. LTD.,
NIPPON KAYAKU
NIPRO CORPORATION
NIPRO PHARMA CORPORATION
NITTO MEDIC CO., LTD.
NITTO PHARMACEUTICAL INDUSTRIES,LTD.
Nichi-iko Pharmaceutical Co.,Ltd
Nippon Boehringer Ingelheim Co., Ltd.
Nippon Shika Yakuhin Co.,Ltd
Nippon Shinyaku Co., Ltd.
Nippon Zoki Pharmaceutical Co., Ltd.
Nippon-Chemiphar CO.,LTD
Nipro ES Pharma co.,Ltd
Nissin Pharmaceutical Co.,LTD.
Nitten Pharmaceutical Co.,Ltd.
Nobelpharma Co., Ltd.
Novartis Pharma K.K.
Novo Nordisk Pharma Ltd.
OHARA Pharmaceutical Co.,Ltd.
OHSUGI PHARMACEUTICAL CO.,LTD.
OKAYAMA TAIHO Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd.
OrphanPacific,Inc.
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Factory, Inc.
POLA PHARMA INC.
Pfizer Pharmaceuticals Inc.
RAKOOL PHARMACEUTICAL MARKETING Co.,Ltd.
Rakuten Medical Japan K.K.
Recordati Rare Diseases Japan K.K.
SANDOZ K.K.
SANWA KAGAKU KENKYUSHO CO.,LTD.
SBI Pharmaceuticals Co., Ltd.
SEIKOEIYOYAKUHIN Co.,Ltd.
SENJU PHARMACEUTICAL CO.,LTD.
SHOWA YAKUHIN KAKO CO., LTD.
SIOE PHARMACEUTICAL CO.,LTD.
SKI Pharma Co.Ltd.
Sanofi K.K.
Santen Pharmaceutical Co.,Ltd.
Sanwa Shoyaku Company Limited
Sato Pharmaceutical CO.,Ltd
Sawai Pharmaceutical Co.,Ltd.
Shiono Chemical Co., Ltd.
Shionogi & Co., Ltd.
Shire Japan KK
Sumitomo Dainippon Pharma Co.,Ltd.
Sun Pharma Japan Limited
SymBio Pharmaceuticals Limited
TAIHO Pharmaceutical Co.,LTD.
TAIYO Pharma Co., Ltd.
TAKATA SEIYAKU Co., Ltd.
TATSUMI KAGAKU CO.,LTD.
TEIJIN PHARMA LIMITED
TOA EIYO LTD.
TOA SHINYAKU CO., LTD.
TOBISHI PHARMACEUTICAL CO.,LTD
TOWA PHARMACEUTICAL CO., LTD.
TSURUHARA Pharmaceutical Co.,Ltd.
Taikoseido Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited.
Tamura Pharmaceutical Co., Ltd.
Teika Pharmaceutical Co.,Ltd.
Teikoku Seiyaku Co., Ltd.
Teva Takeda Pharma Ltd.
Teva Takeda Yakuhin Ltd.
Torii Pharmaceutical Co.,Ltd
Tsumura & Co.
UCB Japan Co., Ltd.
Viatris Pharmaceuticals Inc.
ViiV Healthcare K.K.
WAKAMOTO PHARMACEUTICAL CO., LTD
YUTOKU PHARMACEUTICAL IND. CO., LTD
Yakult Honsha Co., Ltd.
Yoshida Pharmaceutical Co., Ltd.
ZENSEI PHARMACEUTICAL INDUSTRIES CO., LTD.
ZONNEBOD PHARMACEUTICAL CO.,LTD
Zenyaku Kogyo Co.,Ltd.
Zeria Pharmaceutical Co., Ltd.
kakenshoyaku.Co,.LTD
minophagen pharmaceutical co., ltd.
sannova company limited
yoshindo
With english version
With / Without english version
All type
Internal
External
Self-injection
Injection
All area
1:Agents affecting nervous system and sensory organs
11:Central nervous system agents
12:Peripheral nervous system agents
13:Sensory organ agents
19:Other agents affecting nervous system and sensory organs
2:Agents affecting individual organs
21:Cardiovascular agents
22:Respiratory organ agents
23:Digestive organ agents
24:Hormones
25:Urogenital and anal organ agents
26:Epidermides
27:Dental preparations
29:Other agents affecting individual organs
3:Agents affecting metabolism
31:Vitamins
32:Nutrients, tonics
33:Blood and body fluid agents
34:Dialysis agents
39:Other agents affecting metabolism
4:Agents affecting cellular function
41:Cellular function activating agents
42:Antineoplastics
43:Radioactive drugs
44:Allergic agents
49:Other agents affecting cellular function
5:Crude drugs and Chinese medicine formulations
51:Crude drugs
52:Traditional Chinese medicines
59:Other crude drugs and Chinese medicine formulations
6:Agents against pathologic organisms and parasites
61:Antibiotics
62:Chemotherapeutics
63:Biological preparations
64:Parasitics (systemic)
69:Other agents against pathogenic organisms and parasites
7:Agents not mainly for therapeutic purpose
71:Dispensing medicines
72:Intracorporeal diagnostic agents
73:Public health agents
74:Extracorporeal diagnostic agents
79:Other agents not mainly for therapeutic purpose
8:Narcotics
81:Alkaloidal narcotics
82:Non-alkaloidal narcotics
89:Other narcotics
Browse by drug name A-Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z